Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

SHE:002932 Revenue

Wuhan Easy Diagnosis Biomedicine had revenue of 69.96M CNY in the quarter ending March 31, 2025, with 14.76% growth. This brings the company's revenue in the last twelve months to 359.06M, down -18.04% year-over-year. In the year 2024, Wuhan Easy Diagnosis Biomedicine had annual revenue of 350.06M, down -53.30%.

• Revenue (ttm): 359.06M
• Revenue Growth: -18.04%
• P/S Ratio: 11.98
• Revenue / Employee: 442.19K
• Employees: 812
• Market Cap: 4.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	350.06M	-399.47M	-53.30%
Dec 31, 2023	749.54M	-9.78B	-92.88%
Jan 1, 2023	10.53B	7.70B	272.12%
Jan 1, 2022	2.83B	1.87B	195.05%
Dec 31, 2020	959.10M	777.94M	429.43%